# ClinicalTrials.gov record history: NCT03375788

- Peptide profile: [tesamorelin](https://peptidescanner.com/peptides/tesamorelin/)
- Human timeline: https://peptidescanner.com/stories/clinicaltrials-gov-nct03375788-tesamorelin/
- JSON object: https://peptidescanner.com/clinical-trials-history/v1/trials/nct03375788.json
- Source observed: 2026-08-23T23:32:33.000Z
- Published by PeptideScanner: 2026-08-23
- Source observation SHA-256: `6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e`
- Object content SHA-256: `b741cc742c4575d93a7ad3f00397e3bee3cb0c5a3964810744b8bf891a2f4bd9`

## Reporting boundary

ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.

## Public history versions

| Version | Submitted | Last submitted QC | Status | Study type | Source-declared changed modules | Exact source | Record SHA-256 |
| ---: | --- | --- | --- | --- | --- | --- | --- |
| 1 | 2017-12-13 | 2017-12-13 | NOT_YET_RECRUITING | INTERVENTIONAL | None listed | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03375788?a=1&tab=history) | `f29ddafb86ac33f4f800e50592be16645a05af9fe21e4bb0c31e732c4d87e262` |
| 2 | 2017-12-15 | 2017-12-15 | NOT_YET_RECRUITING | INTERVENTIONAL | Arms and Interventions, Conditions, Outcome Measures, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03375788?a=2&tab=history) | `9117437b792f307424d986653641ec22bd6dbd549eaa4b65e9ff5093d206eca6` |
| 3 | 2018-08-14 | 2018-08-14 | NOT_YET_RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03375788?a=3&tab=history) | `4f8a9d127855547d30fbda728f17cc25101035dc69f8acc1ee46c632bef7d731` |
| 4 | 2018-10-19 | 2018-10-19 | NOT_YET_RECRUITING | INTERVENTIONAL | Sponsor/Collaborators, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03375788?a=4&tab=history) | `b7315ca1cefd241efc7d0949da64519ece42c7b51156a99e40ebed4b3c6cdf1f` |
| 5 | 2019-02-21 | 2019-02-21 | RECRUITING | INTERVENTIONAL | Contacts/Locations, Outcome Measures, Sponsor/Collaborators, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03375788?a=5&tab=history) | `5228676b5e5d0d95c5e9d1173d0731cf83c1f9907f17df52bafb851c9a9b1cec` |
| 6 | 2019-11-19 | 2019-11-19 | RECRUITING | INTERVENTIONAL | Arms and Interventions, Eligibility, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03375788?a=6&tab=history) | `431b08e31e2f8eb4ee344d1d1cd1f013bbe0bf53016e802b1e9787054b27a4f3` |
| 7 | 2021-03-29 | 2021-03-29 | RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03375788?a=7&tab=history) | `6055a576b9bcce373580c16a15e1be38e2e119e8846d74ff28dbd7d6458d0c80` |
| 8 | 2022-08-11 | 2022-08-11 | RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03375788?a=8&tab=history) | `500abdd7cad92b58eabac23d8084a163fb1402ede4c10e0feff6a68960fb3e6e` |
| 9 | 2023-05-29 | 2023-05-29 | ACTIVE_NOT_RECRUITING | INTERVENTIONAL | Contacts/Locations, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03375788?a=9&tab=history) | `5210e37bebab0d9673932c40b4902933a709f7f9d2aa06368974c7a37ad182c0` |
| 10 | 2024-09-11 | 2024-09-11 | ACTIVE_NOT_RECRUITING | INTERVENTIONAL | Oversight, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03375788?a=10&tab=history) | `7d6b65e6e69d2998a244a444c10068f395d048fdaee51e1555fe3b6b68670ac4` |
| 14 | 2025-11-06 | 2025-11-06 | COMPLETED | INTERVENTIONAL | Adverse Events, Outcome Measures, Outcome Measures (Results), Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03375788?a=14&tab=history) | `96f23bb33b391960f901b9ca8a45c8936b23118896ef6cd7f66df5a5e5d74c62` |
